Cargando…

Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer

PURPOSE: Head and neck squamous cell carcinomas (HNSCCs) are a molecularly, histologically, and clinically heterogeneous set of tumors originating from the mucosal epithelium of the oral cavity, pharynx, and larynx. This heterogeneous nature of HNSCC is one of the main contributing factors to the la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spielvogel, Clemens P., Stoiber, Stefan, Papp, Laszlo, Krajnc, Denis, Grahovac, Marko, Gurnhofer, Elisabeth, Trachtova, Karolina, Bystry, Vojtech, Leisser, Asha, Jank, Bernhard, Schnoell, Julia, Kadletz, Lorenz, Heiduschka, Gregor, Beyer, Thomas, Hacker, Marcus, Kenner, Lukas, Haug, Alexander R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816299/ https://www.ncbi.nlm.nih.gov/pubmed/36161512 http://dx.doi.org/10.1007/s00259-022-05973-9

Ejemplares similares

Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort
por: Schnoell, Julia, et al.
Publicado: (2020)

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2022)

Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2021)

β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)

Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival
por: Schnoell, Julia, et al.
Publicado: (2020)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
por: Jank, Bernhard J., et al.
Publicado: (2021)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro
por: Maier, Tobias, et al.
Publicado: (2022)

High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
por: Scheiflinger, Alexandra, et al.
Publicado: (2023)

AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck
por: Kadletz, Lorenz C., et al.
Publicado: (2019)

Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro
por: Jank, Bernhard J., et al.
Publicado: (2022)

Automated data preparation for in vivo tumor characterization with machine learning
por: Krajnc, Denis, et al.
Publicado: (2022)

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)

The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer
por: Haas, Markus, et al.
Publicado: (2023)

Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab
por: Haas, Markus, et al.
Publicado: (2023)

Breast Tumor Characterization Using [(18)F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics
por: Krajnc, Denis, et al.
Publicado: (2021)

Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts
por: Grahovac, M., et al.
Publicado: (2023)

The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines
por: Haas, Markus, et al.
Publicado: (2022)

The Potential Prognostic Value of a Novel Hematologic Marker Fibrinogen-to-Lymphocyte Ratio in Head and Neck Adenoid-Cystic Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022)

Evaluation of the External Jugular Vein Overlying the Sternocleidomastoid Muscle as Venous Lymph-Node Flap
por: Kadletz-Wanke, Lorenz, et al.
Publicado: (2022)

Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-PSMA-11 PET/MRI
por: Papp, L., et al.
Publicado: (2020)

Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study
por: Jank, Bernhard J., et al.
Publicado: (2019)

Error mitigation enables PET radiomic cancer characterization on quantum computers
por: Moradi, S., et al.
Publicado: (2023)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

Sex-specific radiomic features of L-[S-methyl-(11)C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability
por: Papp, Laszlo, et al.
Publicado: (2023)

Radiogenomics of lung cancer
por: Wong, Chi Wah, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma
por: Friedl, Marlene, et al.
Publicado: (2022)

Clinical data classification with noisy intermediate scale quantum computers
por: Moradi, S., et al.
Publicado: (2022)

Radiomics and radiogenomics for precision radiotherapy
por: Wu, Jia, et al.
Publicado: (2018)

Radiogenomics and Radiomics in Liver Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Precision Medicine in Radiomics and Radiogenomics
por: Monti, Serena
Publicado: (2022)

Analysis of hematological parameters as prognostic markers for toxicity and survival of (223)Radium treatment
por: Leisser, Asha, et al.
Publicado: (2018)

[(11)C]acetate PET as a tool for diagnosis of liver steatosis
por: Nejabat, Marzieh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_35u2mieh0c1ibre6bljipl5c9n